Mary Larijani, MD

About Mary Larijani, MD

Titles

Attending Physician

Certifications

Dermatology – American Board of Dermatology

Awards and Honors

2020, Top Doctor, Main Line Today
2016, Stelwagon Competition First Prize Winner, Section on Dermatology of The College of Physicians of Philadelphia
2015, Magna Cum Laude, Sidney Kimmel Medical College of Thomas Jefferson University
2014, Alpha Omega Alpha Honor Medical Society, Junior Induction, Pennsylvania Alpha Chapter
2014, Third Place in Poster Competition, AOA Research Symposium, Sidney Kimmel Medical College at Thomas Jefferson University
2013, American Skin Association’s Medical Student Grant
2013, Hobart Amory Hare Honor Society, Sidney Kimmel Medical College at Thomas Jefferson University
2012, Lavine Scholarship, Thomas Jefferson University
2012, American Dermatological Association Medical Student Fellowship
2011, Graduated with Honors, University of Michigan

Leadership and Memberships

Memberships in Professional Organizations

2016-present, American Academy of Dermatology
2016-present, Society for Pediatric Dermatology
2016-present, Women's Dermatologic Society

Education & training

Medical Degree

MD - Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA

Internship

Internal Medicine - Lankenau Medical Center, Wynnewood, PA

Residency

Dermatology - Thomas Jefferson University, Philadelphia, PA
Dermatology - Drexel University College of Medicine/Hahnemann University Hospital, Philadelphia, PA

Fellowship

Dermatology - The Children’s Hospital of Philadelphia, Philadelphia, PA

Team affiliations

 View fewer team affiliations View all team affiliations

Publications

Publications

2021

Tamazian S, Oboite M, Larijani M, Oliver B, Milbar H, Jen M, Treat JR.: Toxic erythema of chemotherapy affecting the ears of an infant: A case report. Pediatr Dermatol 38: 512-513, Mar 2021.

Mary Larijani MD, Adam I. Rubin MD, Melinda Jen MD: Recurrent blisters in a 6-year-old girl. Pediatric Dermatology 38(3), May/June 2021.

2018

Nadhan KS, Larijani M, Abbott J, Doyle AM, Linfante AW, Chung CL.: Prevalence and Types of Genital Lesions in Organ Transplant Recipients. JAMA Dermatol 154: 323-329, Mar 2018. PMCID: PMC5885815

Neidig L, Jin A, Larijani M, Chung CL.: Penile basal cell carcinoma in a black kidney transplant recipient. JAAD Case Rep 4: 969-971, Oct 2018. PMCID: PMC6214887

2017

Kemp DM, Pidich A, Larijani M, Jonas R, Lash E, Sato T, Terai M, De Pizzol M, Allegretti M, Igoucheva O, Alexeev V.: Ladarixin, a dual CXCR1/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironment. Oncotarget 8: 14428-14442, Feb 2017. PMCID: PMC5362416

2013

Igoucheva, O, Grazzini, M, Pidich, A, Kemp, D M, Larijani, M, Farber, M, Lorton, J, Rodeck, U, Alexeev, V: Immunotargeting and eradication of orthotopic melanoma using a chemokine-enhanced DNA vaccine. Gene Ther 20: 939-48, Sep 2013.

2009

Le S, Finn JP, Larijani ME, Marino MJ, Schaffhauser H.: Detection of low level histamine H3 receptor occupancy by autoradiography. J Neurosci Methods 185: 70-5, Dec 2009.

Abstracts (includes Posters and Scientific Presentations)

2018

Larijani M. Erythema Elevatum Diutinum: Not your average leukocytoclastic vasculitis. Oral presentation: Philadelphia Dermatological Society. Philadelphia, PA. October 2018.

Lectures by Invitation
2018

Larijani M. "Erythema Elevatum Diutinum: Not your average leukocytoclastic vasculitis.", Philadelphia Dermatological Society, Philadelphia, PA. October 2018.

Larijani M. "Racial Differences in Rates of Malignant and Infectious Cutaneous Genital Disease After Solid Organ Transplantation." American Transplant Congress. Seattle, WA. June 2018.

Editorials, Reviews, Chapters
2018

Griffin Jr. TD, Larijani M, Hazan E, Saedi N.: Anatomy of Facial Vasculature/Musculature. Reconstructive Dermatologic Surgery. Shang I Brian Jiang (eds.). Jaypee Brothers Medical Publishers Ltd. 2018.

Patient experience rating

(based on 108 submissions)
  • Provider listened carefully
    4.9 of 5
  • Trust provider with care
    4.8 of 5
  • Provider gave enough info about child's health
    4.8 of 5
  • Would recommend the provider
    4.9 of 5
Learn about the patient experience rating system

About the Patient Experience Rating System

The patient experience rating is an average of all responses to the care provider-related questions from surveys submitted by patient families and verified by our survey partner National Research Corporation (NRC Health), an independent company that specializes in patient experience. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question. Responses are measured using percent positive scoring. Percent positive is the percentage of respondents who answered with the most desirable response. We are committed to transparency and sharing the voices of our patients and families. Comments are reviewed before posting to ensure accuracy, privacy, and relevance. To provide meaningful feedback, comments are displayed on provider profiles once a sufficient number have been received. All feedback is also shared internally to support learning, recognition, and continuous improvement. The comments reflect the experiences and perspectives of the patients and families who submitted them. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.